Regeneron buys 23andMe for $256m after bankruptcy | Business and Economy
Sale of genetic testing company raises concerns about privacy of 23andMe’s 15 million customers. Regeneron Pharmaceuticals has bought the genetic…
Sale of genetic testing company raises concerns about privacy of 23andMe’s 15 million customers. Regeneron Pharmaceuticals has bought the genetic…
Genetic testing startup 23andMe, which filed for bankruptcy earlier this year, announced on Monday that it has agreed to sell…
Pharmaceutical maker Regeneron announced Monday it will buy genetic testing company 23andMe for $256 million following a bankruptcy auction. Regeneron…
A view of the 23andMe headquarters in Sunnyvale, California, on March 25, 2025. Tayfun Coskun | Anadolu | Getty Images…
DNA testing company 23andMe (MEHCQ) is being purchased out of bankruptcy by large-cap drugmaker Regeneron (REGN), for $256 million. The…